end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableAndAccruedLiabilitiesCurrent,AccountsPayableCurrent,AccretionExpense,AccruedIncomeTaxesCurrent,AccruedLiabilitiesCurrent,AccruedVacationCurrent,AccumulatedOtherComprehensiveIncomeLossNetOfTax,AdditionalPaidInCapital,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts,Assets,AssetsCurrent,CashAndCashEquivalentsAtCarryingValue,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,CashFDICInsuredAmount,ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1,ClassOfWarrantOrRightOutstanding,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,DeferredTaxAssetsGross,DeferredTaxAssetsInvestments,DeferredTaxAssetsNet,DeferredTaxAssetsOperatingLossCarryforwards,DeferredTaxAssetsOther,DeferredTaxAssetsTaxCreditCarryforwardsResearch,DeferredTaxAssetsValuationAllowance,DepositsAssetsNoncurrent,DerivativeGainLossOnDerivativeNet,DerivativeLiabilitiesCurrent,DerivativeLiabilitiesNoncurrent,EarningsPerShareBasicAndDiluted,EffectiveIncomeTaxRateContinuingOperations,EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,ForeignCurrencyTransactionGainLossBeforeTax,ForeignCurrencyTransactionGainLossUnrealized,GeneralAndAdministrativeExpense,IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest,IncomeTaxExpenseBenefit,IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance,IncomeTaxReconciliationForeignIncomeTaxRateDifferential,IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate,IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost,IncomeTaxReconciliationOtherAdjustments,IncomeTaxReconciliationPriorYearIncomeTaxes,IncreaseDecreaseInAccountsPayableAndAccruedLiabilities,IncreaseDecreaseInAccruedIncomeTaxesPayable,IncreaseDecreaseInDerivativeLiabilities,IncreaseDecreaseInPrepaidExpense,IncreaseDecreaseInReceivables,InterestIncomeDepositsWithFinancialInstitutions,LesseeOperatingLeaseDiscountRate,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,LongTermDebtCurrent,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,NumberOfOperatingSegments,OperatingExpenses,OperatingLeaseCost,OperatingLeaseLiability,OperatingLeaseLiabilityCurrent,OperatingLeaseLiabilityNoncurrent,OperatingLeasePayments,OperatingLeaseRightOfUseAsset,OperatingLeaseRightOfUseAssetAmortizationExpense,PaymentsOfFinancingCosts,PaymentsOfMergerRelatedCostsFinancingActivities,PaymentsOfStockIssuanceCosts,PaymentsToAcquireShortTermInvestments,PrepaidExpenseAndOtherAssets,PrepaidExpenseCurrent,PrepaidInsurance,ProceedsFromIssuanceOfCommonStock,ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans,ProceedsFromIssuanceOfWarrants,ProceedsFromOtherDeposits,ProceedsFromSaleOfShortTermInvestments,ProceedsFromStockOptionsExercised,ProceedsFromWarrantExercises,ReceivablesNetCurrent,RepaymentsOfDebt,ResearchAndDevelopmentExpense,RetainedEarningsAccumulatedDeficit,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice,ShortTermInvestments,StockholdersEquity,StockIssuedDuringPeriodSharesStockOptionsExercised,StockIssuedDuringPeriodValueAcquisitions,StockIssuedDuringPeriodValueEmployeeStockPurchasePlan,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValueStockOptionsExercised,WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2020-09-30,2020-12-15,10-K,ESSA PharmaÂ Inc.,EPIX,CIK0001633932,USD,1144230.0,678643.0,12992.0,0.0,310604.0,154983.0,-2076479.0,31204284.0,7522608.0,3144003.0,80574565.0,80296928.0,56320763.0,56320763.0,2998040.0,,1.73,9272977.0,32064411.0,32064411.0,131086364.0,22875000.0,39000.0,0.0,21297000.0,0.0,0.0,22875000.0,277637.0,-110856.0,0.0,127376.0,-1.04,0.27,-58181.0,-44851.0,-13059.0,11373952.0,-23734017.0,-288647.0,4210000.0,1013000.0,-6408000.0,2031000.0,21000.0,-307000.0,-46358.0,-20000.0,-110856.0,1262280.0,-89938.0,559719.0,0.12,1330700.0,80574565.0,1203324.0,0.0,41776625.0,-21737252.0,-16983152.0,-23445370.0,1.0,24138029.0,119384.0,59094.0,59094.0,0.0,119384.0,55162.0,110324.0,32235.0,64804.0,3447954.0,22011337.0,124528.0,1600128.0,825014.0,48990000.0,80714.0,,274085.0,0.0,915.0,257172.0,309538.0,3199799.0,12145968.0,-80970304.0,7522608.0,1859826.0,3.52,30461.0,28.46,4218000.0,2.98,5309584.0,3.42,2.2,3.31,22011337.0,79243865.0,416.0,,80714.0,48990000.0,915.0,22443893.0
2020-12-31,2021-02-11,10-Q,ESSA PharmaÂ Inc.,EPIX,CIK0001633932,USD,2005389.0,1375781.0,1181.0,,609711.0,19897.0,-2076479.0,29289327.0,1204985.0,,76174988.0,75897351.0,52484512.0,52484512.0,-3836251.0,,2.06,7779473.0,33605383.0,33605383.0,134387525.0,,,,,,,,277637.0,89130.0,0.0,38246.0,-0.2,,-44595.0,7196.0,-13952.0,2208917.0,-6563853.0,-35149.0,,,,,,,867841.0,0.0,89130.0,-462405.0,-102308.0,35691.0,0.12,2073623.0,76174988.0,2035377.0,,150932.0,0.0,-3942588.0,-6528704.0,1.0,6695870.0,,29988.0,29988.0,,30287.0,27581.0,27581.0,0.0,,0.0,0.0,95150.0,1137723.0,604011.0,,27369.0,,,0.0,153701.0,149.0,231191.0,0.0,4485772.0,-87499008.0,1204985.0,2071960.0,3.52,42000.0,3.4,1524646.0,5.52,6750023.0,4.24,3.64,7.0,22016344.0,74101365.0,42207.0,,27369.0,,153701.0,33343488.0
2021-03-31,2021-05-06,10-Q,ESSA PharmaÂ Inc.,EPIX,CIK0001633932,USD,3085397.0,1690676.0,,,1351833.0,42888.0,-2076479.0,31208296.0,2663684.0,9168801.0,210001054.0,209382292.0,151562303.0,151562303.0,,,2.35,6728398.0,40417857.0,40417857.0,276740509.0,,,,,,,,277637.0,-1128216.0,0.0,1166462.0,-0.36,,,7649.0,,4615332.0,-12965247.0,0.0,,,,,,,,,,,,39208.0,0.05,4592983.0,210001054.0,3179691.0,,,,,-12965247.0,,11883888.0,,341125.0,94294.0,246830.0,,341125.0,,,,,,115130.0,491962.0,374457.0,,,,,,,,293106.0,,7268257.0,-100464255.0,,2232820.0,3.51,,,,,6726642.0,4.53,,,57034921.0,205408071.0,,,,149999985.0,776985.0,36484041.0
2021-06-30,2021-08-16,10-Q,ESSA PharmaÂ Inc.,EPIX,CIK0001633932,USD,2910964.0,907537.0,,,1702793.0,300634.0,-2076479.0,33619332.0,2783944.0,60649.0,203524045.0,202957938.0,145194181.0,145194181.0,,,2.92,5359750.0,41854916.0,41854916.0,277370996.0,,,,,,,,268574.0,568954.0,0.0,597508.0,-0.21,,,-34084.0,,3117900.0,-8751211.0,800.0,,,,,,,,,,,,80394.0,0.05,3826462.0,203524045.0,3008727.0,,,,,-8752011.0,,9366475.0,,317990.0,97763.0,220227.0,,297533.0,,,,,,188610.0,463789.0,149179.0,,,,,,,,231146.0,,6231908.0,-109216266.0,,2496961.0,3.5,,,,,6803230.0,5.2,,,57068822.0,199697583.0,,,61948.0,,256147.0,41018024.0
2021-09-30,2021-11-18,10-K,ESSA PharmaÂ Inc.,EPIX,CIK0001633932,USD,3808944.0,1425871.0,9570.0,,2062441.0,320632.0,-2076479.0,36442620.0,9476113.0,9229450.0,198165818.0,197598077.0,137825024.0,137825024.0,81504261.0,250000.0,4.84,3234750.0,43984346.0,43984346.0,277415176.0,33169000.0,29000.0,0.0,29749000.0,79000.0,210000.0,33169000.0,259455.0,107024.0,0.0,20352.0,-0.96,0.27,-56115.0,-16041.0,0.0,12884581.0,-36839810.0,-34349.0,10344000.0,1260000.0,-9947000.0,1575000.0,-49000.0,-725000.0,2667738.0,0.0,107024.0,563572.0,157575.0,234997.0,0.05,4160266.0,198165818.0,3929663.0,,141990753.0,-35014766.0,-25415611.0,-36805461.0,1.0,37165790.0,,330970.0,120719.0,210251.0,100282.0,308286.0,109464.0,0.0,0.0,9229450.0,57026103.0,190317.0,2181882.0,1751052.0,149999985.0,133071.0,,0.0,22000000.0,1186833.0,596.0,489012.0,0.0,24258989.0,-117775765.0,9476113.0,2799226.0,3.49,72390.0,4.46,1889646.0,8.04,6803230.0,5.2,3.68,9.87,57102159.0,194005552.0,323610.0,,133071.0,149999985.0,1186833.0,38480378.0
2021-12-31,2022-02-03,10-Q,ESSA PharmaÂ Inc.,EPIX,CIK0001633932,USD,3524590.0,1562511.0,3884.0,,1635272.0,326807.0,-2076479.0,38843947.0,2500091.0,,191486149.0,190948855.0,121058121.0,121058121.0,-16766903.0,250000.0,,3234750.0,44015870.0,44015870.0,277645624.0,,,,,,,,259455.0,-99318.0,0.0,119670.0,-0.21,,-46524.0,13169.0,-24759.0,3062170.0,-9097819.0,100.0,,,,,,,-279954.0,,-99318.0,-434310.0,-504381.0,74584.0,0.05,3946741.0,191486149.0,3657770.0,,99311.0,-11000040.0,-5819650.0,-9097919.0,1.0,9086254.0,,302481.0,133180.0,169301.0,32373.0,277839.0,30447.0,,,,15014700.0,42365.0,1747540.0,1276479.0,,27360.0,,,4000000.0,104324.0,0.0,2028.0,,6019759.0,-126873684.0,2500091.0,3528789.0,3.99,104584.0,3.18,120000.0,8.47,6789566.0,5.3,3.61,8.47,68141166.0,187539408.0,29080.0,,27360.0,,104324.0,43989773.0
